Olivia Martinez
Academic Appointments
- Professor (Research), Surgery - Multi-Organ Transplantation
- Member, Bio-X
- Member, Cancer Center
Contact Information
-
Academic Offices
Administrative Contact Sharon Dickow Administrative Associate Email Tel Work 8-6248
Professional Snapshot
Administrative Appointments
- Director, Pre-Doctoral Program, Immunology IDP, Stanford University School of Medicine (2008 - present)
Honors and Awards
- Distinguished Service Award, American Association of Immunologists (2007)
- Faculty Mentor of the Year, Program in Immunology, Stanford University School of Medicine (2005)
- Fujisawa Basica Science Award, American Society of Transplantation (2004)
Professional Education
| Ph.D.: | Univ of California, Berkeley, Immunology (1982) |
| B.S.: | Univ of Southern California, Biological Sciences (1976) |
Graduate & Fellowship Program Affiliations
Scientific Focus
Research Interests
There are two major areas of focus in the laboratory. First, we are interested in Epstein Barr Virus-mediated mechanisms of immune evasion with particular focus on resistance to cell death receptor pathways of apoptosis in EBV B cell lymphomas, the characterization of the human T cell response to EBV infected B cells and effects of immunosuppressive drugs on growth and survival of EBV B cell lymphomas. The second area of study addresses tolerance induction in solid organ transplantation. In particular we are examining the generation and characterization of regulatory T cells in allogeneic responses and the role of alternate co-stimulatory molecules in alloreactivity.
Publications
- Activation of the JAK/STAT pathway in Epstein Barr virus+-associated posttransplant lymphoproliferative disease: role of interferon-gamma. Am J Transplant. 2009; (10): 2292-302
- Decreases in circulating CD4+CD25hiFOXP3+ cells and increases in intragraft FOXP3+ cells accompany allograft rejection in pediatric liver allograft recipients. Pediatr Transplant. 2009; (1): 70-80
- Rapamycin, but not cyclosporine or FK506, alters natural killer cell function. Transplantation. 2008; (1): 145-9
- Epstein-Barr virus, rapamycin, and host immune responses. Curr Opin Organ Transplant. 2008; (6): 563-8
- Tumor-derived variants of Epstein-Barr virus latent membrane protein 1 induce sustained Erk activation and c-Fos. J Biol Chem. 2008; (52): 36573-85
